Abstract:OBJECTIVE: The expression of S100A6 (calcyclin), a member of the S100 calcium binding protein family, is elevated in a number of malignant tumors, but there have been few reports about its expression in gastric cancer. The aim of this study was to investigate its expression regulations in human gastric cancer and noncancerous mucosa, and the response to chemotherapeutic drugs in the gastric cancer cell line.MATERIALS AND METHODS: In one matched gastric cancer sample pair, the serial analysis of gene expression (SAGE) experiment was conducted to compare the gene expression profiles between cancerous and adjacent tissues. To detect the expression regulations among more cancerous tissues, microarrays were carried out and real-time RT-PCR was conducted to validate the results. At the protein level, Western blot and tissue microarray (TMA) examination were further used to verify S100A6 expression. The regulation. detection of S100A6 with flurouracil and doxorubicin at the mRNA and protein level was performed in the SGC7901 cell line.RESULTS: With the SAGE strategy, five times more S100A6 tags were identified in cancer tissues than in normal tissues. With the cDNA microarray, S100A6 was found to be significantly upregulated in 21 of 42 (50%) nonselective gastric cancers. In 10 other paired samples, the upregulation of S 100A6 was consolidated with RT-PCR and Western blot analysis as well. A total of 14 endoscopy-sectioned gastric noncancerous lesions and corresponding normal gastric mucosa were also applied to profile the gene expression; both cDNA microarray and RT-PCR demonstrated no significant alterations of S 100A6 at the mRNA level. TMA examination showed that 34 of 52 (65.4%) cancer samples were positively stained, while only 17 of 80 (21.3%) noncancerous lesions were positively detected and all nine normal mucosae were detected to be negative. An in vitro experiment showed that in the gastric cell line SGC-7901, S100A6 mRNA was detected to be upregulated from 24 to 72 h after treatment with 5 mg/L 5-flurouracil or 0.3 mg/L doxorubicin, and there were two wave upregulations of the S100A6 protein.CONCLUSION: The observed regulated expression of S100A6 suggests that it is associated with gastric cancer tumorigenesis and quantitation of S100A6 is a promising tool for diagnosis of gastric cancer.

In Silico Analysis and Verification of S100 Gene Expression in Gastric Cancer

[Expression and Clinical Significance of CD44v6 and Scd44v6 in Gastric Carcinoma].

Identification of Significant Biomarkers and Pathways Associated with Gastric Carcinogenesis by Whole Genome-Wide Expression Profiling Analysis

Distinct Prognostic Roles of S100 Mrna Expression in Gastric Cancer.

Clinical Significance of S100A2 Expression in Gastric Cancer

An integrated bioinformatics analysis of the S100 in head and neck squamous cell carcinoma

Expression and clinical implication of S100A12 in gastric carcinoma

[Regulation Mechanism Study of S100A6 on Invasion and Metastasis in Gastric Cancer].

The expression and biological significance of S100A6 protein in gastric carcinoma tissue

[Clinical Significance of S100A8 and S100A9 Expression in Gastric Cancer].

S100A gene family: immune-related prognostic biomarkers and therapeutic targets for low-grade glioma

S100a6 Overexpression is Associated with Poor Prognosis and is Epigenetically Up-Regulated in Gastric Cancer

Presence of S100A9-positive Inflammatory Cells in Cancer Tissues Correlates with an Early Stage Cancer and a Better Prognosis in Patients with Gastric Cancer

Differential Expression of COL6 Family is a Potential Tumor Marker for Predicting Gastric Cancer

[Expressions of Nm23, P53 and S100A4 Proteins and Their Relationships with Metastasis Potential in Gastric Carcinoma].

Overexpression of S100A4 is Closely Associated with the Progression and Prognosis of Gastric Cancer in Young Patients.

The role of the S100A8/S100A9 in gastric tumor progression

Upregulated Expression Of S100a6 In Human Gastric Cancer

Frequent S100A4 Expression with Unique Splicing Pattern in Gastric Cancers: A Hypomethylation Event Paralleled with E-cadherin Reduction and Wnt Activation.

Prognostic Value of S100 Family Mrna Expression in Hepatocellular Carcinoma

[Analysis of Human Gastric Cancer by Transcriptome and Proteome Profiling].